- Ribociclib-Induced Erythema Dyschromicum Perstans (Ashy Dermatosis)–Like Pigmentation in a Metastatic Breast Cancer Patient
-
Mariano M, Donati P, Cameli N, Pigliacelli F, Morrone A, Cristaudo A
- KMID: 2515173
- J Breast Cancer.
- 2021 Feb;24(1):117-121.
- doi: 10.4048/jbc.2021.24.e1
Ribociclib is a selective cyclin-dependent kinase (CDK) 4/6 inhibitor that has been approved in combination with endocrine therapy for the treatment of hormone receptor-positive/ human epidermal growth factor 2-negative advanced... -
- CITED
-
- Close
- SHARE
-
- Close
- Paraneoplastic Encephalitis Associated with Locally Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
-
Shay RC, Diamond JR, Kagihara JA, Sams SB
- KMID: 2515172
- J Breast Cancer.
- 2021 Feb;24(1):106-116.
- doi: 10.4048/jbc.2021.24.e2
Paraneoplastic neurologic diseases (PND) are rare but can occur in patients with common malignancies including breast cancer. In patients with hormone receptor (HR)-negative human epidermal growth factor receptor 2 (HER2)-positive... -
- CITED
-
- Close
- SHARE
-
- Close
- Aesthetic Scar-Less Mastectomy and Breast Reconstruction
-
Yang JD, Lee J, Lee JS, Kim EK, Park CS, Park HY
- KMID: 2515163
- J Breast Cancer.
- 2021 Feb;24(1):22-23.
- doi: 10.4048/jbc.2021.24.e11
Surgical approaches in breast cancer have been changing to ensure both oncologic safety and cosmetic results. Although the concept of “oncoplastic breast surgery” has been accepted for decades, breast and... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Significance of ReceptorInteracting Protein 3 and Parkin, Essential Molecules for Necroptosis, in Breast Cancer
-
Won KY, Min SY, Song JY, Lim SJ, Han SA
- KMID: 2515165
- J Breast Cancer.
- 2021 Feb;24(1):34-48.
- doi: 10.4048/jbc.2021.24.e12
Purpose: Receptor-interacting protein 3 (RIP3) is the main initiator of necroptosis. Parkin prevents the formation of the RIP1–RIP3 complex by promoting polyubiquitination of RIP3. However, the mechanism by which necroptosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Standardized Pathology Report for Breast Cancer
-
Cho SY, Park SY, Bae YK, Kim JY, Kim EK, Kim WG, Kwon Y, Lee A, Lee HJ, Lee JS, Park JY, Gong G, Yoon HK
- KMID: 2515161
- J Breast Cancer.
- 2021 Feb;24(1):1-21.
- doi: 10.4048/jbc.2021.24.e5
Given the recent advances in management and understanding of breast cancer, a standardized pathology report reflecting these changes is critical. To meet this need, the Breast Pathology Study Group of... -
- CITED
-
- Close
- SHARE
-
- Close
- Physicians' Awareness of the Breast Cancer Survivors' Unmet Needs in Korea
-
Lee I, Lee J, Lee SK, Shin HJ, Jung SY, Lee JW, Kim Z, Lee MH, Lee J, Youn HJ
- KMID: 2515170
- J Breast Cancer.
- 2021 Feb;24(1):85-96.
- doi: 10.4048/jbc.2021.24.e3
Purpose: Physicians' awareness of their cancer patients' unmet needs is an essential element for providing effective treatment. This study investigated the accuracy of physicians' awareness of breast cancer survivors' unmet... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between Number of Retrieved Sentinel Lymph Nodes and Breast Cancer-related Lymphedema
-
Kim HK, Ju YW, Lee JW, Kim KE, Jung J, Kim Y, Lee HB, Moon HG, Noh DY, Seo KS, Han W
- KMID: 2515168
- J Breast Cancer.
- 2021 Feb;24(1):63-74.
- doi: 10.4048/jbc.2021.24.e9
Purpose: Sentinel lymph node biopsy (SLNB) has become a standard axillary staging surgery for early breast cancer, and the proportion of patients requiring axillary lymph node dissection (ALND) is decreasing.... -
- CITED
-
- Close
- SHARE
-
- Close
- Relation Between Tumor Size and Lymph Node Metastasis According to Subtypes of Breast Cancer
-
Min SK, Lee SK, Woo J, Jung SM, Ryu JM, Yu J, Lee JE, Kim SW, Chae BJ, Nam SJ
- KMID: 2515169
- J Breast Cancer.
- 2021 Feb;24(1):75-84.
- doi: 10.4048/jbc.2021.24.e4
Purpose: Tumor size and lymph node metastasis are important factors that contribute to the progression of breast cancer. We aimed to analyze the relationship between tumor size and lymph node... -
- CITED
-
- Close
- SHARE
-
- Close
- Palbociclib Plus Fulvestrant in Korean Patients from PALOMA-3 With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
-
Kim JH, Im SA, Sim SH, Bananis E, Huang X, Kim HS, Kim SB
- KMID: 2515171
- J Breast Cancer.
- 2021 Feb;24(1):97-105.
- doi: 10.4048/jbc.2021.24.e13
In the PALOMA-3 trial, the median progression-free survival (PFS) was longer among patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC) treated with palbociclib... -
- CITED
-
- Close
- SHARE
-
- Close
- Trends in Axillary Surgery for Treating Ductal Carcinoma In Situ: A Korean Population-based Study
-
Shin YD, Kang G, Jang H, Choi YJ
- KMID: 2515167
- J Breast Cancer.
- 2021 Feb;24(1):49-62.
- doi: 10.4048/jbc.2021.24.e10
Purpose: Ductal carcinoma In Situ (DCIS) is common in South Korea. We evaluated the patterns of axillary surgery among patients with DCIS to highlight the need for compliance with the... -
- CITED
-
- Close
- SHARE
-
- Close
